Rax2 marks the spot

Haploid yeast cells bud next to the site of the previous division (axial pattern), but diploid yeast cells bud from their poles (bipolar pattern). In the 8 December Science, Chen et al. propose that the Rax2 protein marks the cortex to provide a landmark for bipolar budding (Science 2000, 290:1975-1978). Rax2 is an integral membrane protein, discovered following a hunt for mutants defective in bipolar budding. Late in the cell cycle, Rax2 protein localizes to rings associated with division sites

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Haploid yeast cells bud next to the site of the previous division (axial pattern), but diploid yeast cells bud from their poles (bipolar pattern). In the 8 December Science, Chen et al. propose that the Rax2 protein marks the cortex to provide a landmark for bipolar budding (Science 2000, 290:1975-1978). Rax2 is an integral membrane protein, discovered following a hunt for mutants defective in bipolar budding. Late in the cell cycle, Rax2 protein localizes to rings associated with division sites. These rings persist long after production of the protein has ceased. Induction and repression experiments show that the marks are stable, and that existing, localized protein does not shift to new poles or division sites. Rax2 therefore represents a form of long-lasting, epigenetic inheritance. Its discovery suggests that heritable protein marks at the cell cortex may contribute to the development of tissue architecture in higher eukaryotes.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies